Business News/Market/Market Stats/   Sun Pharmaceutical Industries Q1 Results

Sun Pharmaceutical Industries Q1 Results

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs
1,191.40 -5.00 (-0.42%)Updated : 28 Nov 2023
Fiscal Period2024
Period End DateJun 23
Revenue 11940.84
Total Revenue 11940.84
Costof Revenue Total 2758.17
Gross Profit 9182.67
Selling/ General/ Admin Expenses Total 2402.04
Depreciation/ Amortization 651.32
Unusual Expense( Income) 322.87
Other Operating Expenses Total 3450.90
Total Operating Expense 9585.30
Operating Income 2355.54
Interest Inc( Exp) Net- Non- Op Total -788.40
Other Net 204.44
Net Income Before Taxes 2481.14
Provisionfor Income Taxes 468.10
Net Income After Taxes 2013.04
Minority Interest 16.89
Equity In Affiliates -73.90
Net Income Before Extra Items 2022.54
Net Income 2022.54
Income Availableto Com Excl Extra Ord 2022.54
Income Availableto Com Incl Extra Ord 2022.54
Diluted Net Income 2022.54
Diluted Weighted Average Shares 240.78
Diluted EPS Excluding Extra Ord Items 8.40
DPS- Common Stock Primary Issue 0.00
Diluted Normalized EPS 9.49
*All figures in crores except per share values
Recommended For You